Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Sarcoidosis activates diverse transcriptional programs in bronchoalveolar lavage cells.

Gharib SA, Malur A, Huizar I, Barna BP, Kavuru MS, Schnapp LM, Thomassen MJ.

Respir Res. 2016 Jul 26;17(1):93. doi: 10.1186/s12931-016-0411-y.

2.

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis.

Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu G, Shigemitsu H, Barney JB, Culver DA, Hamzeh NY, Wijsenbeek MS, Albera C, Huizar I, Agarwal P, Brodmerkel C, Watt R, Barnathan ES.

Eur Respir J. 2014 Nov;44(5):1296-307. doi: 10.1183/09031936.00000914. Epub 2014 Jul 17.

3.

Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation.

Barna BP, Huizar I, Malur A, McPeek M, Marshall I, Jacob M, Dobbs L, Kavuru MS, Thomassen MJ.

Int J Mol Sci. 2013 Dec 6;14(12):23858-71. doi: 10.3390/ijms141223858.

4.

MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis.

Gharib SA, Johnston LK, Huizar I, Birkland TP, Hanson J, Wang Y, Parks WC, Manicone AM.

J Leukoc Biol. 2014 Jan;95(1):9-18. doi: 10.1189/jlb.1112587. Epub 2013 Aug 20. Erratum in: J Leukoc Biol. 2016 Nov;100(5):1225.

5.

The role of PPARĪ³ in carbon nanotube-elicited granulomatous lung inflammation.

Huizar I, Malur A, Patel J, McPeek M, Dobbs L, Wingard C, Barna BP, Thomassen MJ.

Respir Res. 2013 Jan 23;14:7. doi: 10.1186/1465-9921-14-7.

6.

Alveolar macrophage cathelicidin deficiency in severe sarcoidosis.

Barna BP, Culver DA, Kanchwala A, Singh RJ, Huizar I, Abraham S, Malur A, Marshall I, Kavuru MS, Thomassen MJ.

J Innate Immun. 2012;4(5-6):569-78. doi: 10.1159/000339149. Epub 2012 Jul 3.

7.

Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.

Malur A, Kavuru MS, Marshall I, Barna BP, Huizar I, Karnekar R, Thomassen MJ.

Respir Res. 2012 Jun 14;13:46. doi: 10.1186/1465-9921-13-46.

8.

Lentivirus-ABCG1 instillation reduces lipid accumulation and improves lung compliance in GM-CSF knock-out mice.

Malur A, Huizar I, Wells G, Barna BP, Malur AG, Thomassen MJ.

Biochem Biophys Res Commun. 2011 Nov 18;415(2):288-93. doi: 10.1016/j.bbrc.2011.10.043. Epub 2011 Oct 18.

PMID:
22033401
9.

Alveolar macrophage activation in obese patients with obstructive sleep apnea.

Sharma S, Malur A, Marshall I, Huizar I, Barna BP, Pories W, Dohm L, Kavuru MS, Thomassen MJ.

Surgery. 2012 Jan;151(1):107-12. doi: 10.1016/j.surg.2011.06.035. Epub 2011 Oct 6.

PMID:
21982524
10.

An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.

Kavuru MS, Malur A, Marshall I, Barna BP, Meziane M, Huizar I, Dalrymple H, Karnekar R, Thomassen MJ.

Eur Respir J. 2011 Dec;38(6):1361-7. doi: 10.1183/09031936.00197710. Epub 2011 Apr 8.

11.

Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes.

Huizar I, Malur A, Midgette YA, Kukoly C, Chen P, Ke PC, Podila R, Rao AM, Wingard CJ, Dobbs L, Barna BP, Kavuru MS, Thomassen MJ.

Am J Respir Cell Mol Biol. 2011 Oct;45(4):858-66. doi: 10.1165/rcmb.2010-0401OC. Epub 2011 Mar 11.

12.

Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury.

Gill SE, Huizar I, Bench EM, Sussman SW, Wang Y, Khokha R, Parks WC.

Am J Pathol. 2010 Jan;176(1):64-73. doi: 10.2353/ajpath.2010.090158. Epub 2009 Dec 11.

13.

Matrilysin (Matrix Metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(E)beta(7)-integrin).

Manicone AM, Huizar I, McGuire JK.

Am J Pathol. 2009 Dec;175(6):2319-31. doi: 10.2353/ajpath.2009.090101. Epub 2009 Nov 5.

14.

Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.

Huizar I, Kavuru MS.

Curr Opin Pulm Med. 2009 Sep;15(5):491-8. doi: 10.1097/MCP.0b013e32832ea51c. Review.

PMID:
19561506
15.

Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury.

Choi JE, Lee SS, Sunde DA, Huizar I, Haugk KL, Thannickal VJ, Vittal R, Plymate SR, Schnapp LM.

Am J Respir Crit Care Med. 2009 Feb 1;179(3):212-9. doi: 10.1164/rccm.200802-228OC. Epub 2008 Nov 14.

16.

uPARAP expression during murine lung development.

Smith L, Wagner TE, Huizar I, Schnapp LM.

Gene Expr Patterns. 2008 Sep;8(7-8):486-93. doi: 10.1016/j.gep.2008.06.006. Epub 2008 Jun 28.

Supplemental Content

Loading ...
Support Center